X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (67116) 67116
Book Review (12089) 12089
Publication (4173) 4173
Book / eBook (311) 311
Magazine Article (134) 134
Conference Proceeding (125) 125
Book Chapter (107) 107
Newsletter (107) 107
Newspaper Article (89) 89
Dissertation (66) 66
Government Document (58) 58
Web Resource (18) 18
Presentation (6) 6
Data Set (5) 5
Paper (3) 3
Journal / eJournal (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (61959) 61959
index medicus (59848) 59848
female (50399) 50399
oncology (33166) 33166
middle aged (30509) 30509
breast cancer (27128) 27128
aged (23799) 23799
adult (23728) 23728
cancer (21287) 21287
breast neoplasms - pathology (17318) 17318
breast neoplasms - radiotherapy (15054) 15054
breast neoplasms - surgery (13649) 13649
breast-cancer (13090) 13090
male (12729) 12729
radiotherapy (12417) 12417
prognosis (11549) 11549
chemotherapy (11022) 11022
surgery (10871) 10871
care and treatment (9998) 9998
aged, 80 and over (9157) 9157
breast neoplasms - drug therapy (9016) 9016
research (8167) 8167
treatment outcome (8014) 8014
breast neoplasms - therapy (7882) 7882
metastasis (7807) 7807
medicine & public health (7547) 7547
neoplasm staging (7427) 7427
mastectomy (7302) 7302
tumors (6996) 6996
analysis (6966) 6966
retrospective studies (6753) 6753
combined modality therapy (6547) 6547
carcinoma (6533) 6533
health aspects (6458) 6458
radiology, nuclear medicine & medical imaging (6427) 6427
risk factors (6177) 6177
survival (6145) 6145
follow-up studies (6123) 6123
therapy (6072) 6072
women (5898) 5898
breast neoplasms - mortality (5842) 5842
animals (5773) 5773
abridged index medicus (5562) 5562
hematology, oncology and palliative medicine (5062) 5062
cancer therapies (4940) 4940
breast (4810) 4810
radiation therapy (4555) 4555
diagnosis (4524) 4524
patients (4321) 4321
lymphatic metastasis (4263) 4263
expression (4246) 4246
cell line, tumor (4164) 4164
time factors (4108) 4108
radiotherapy dosage (4085) 4085
radiation-therapy (4040) 4040
cancer patients (3928) 3928
antineoplastic combined chemotherapy protocols - therapeutic use (3919) 3919
survival analysis (3849) 3849
risk (3836) 3836
disease-free survival (3800) 3800
radiation (3759) 3759
survival rate (3738) 3738
breast neoplasms - diagnosis (3654) 3654
immunohistochemistry (3640) 3640
breast neoplasms - metabolism (3596) 3596
antineoplastic agents - therapeutic use (3569) 3569
medicine (3541) 3541
mastectomy, segmental (3535) 3535
apoptosis (3503) 3503
oncology, experimental (3492) 3492
breast neoplasms - genetics (3456) 3456
quality of life (3453) 3453
chemotherapy, adjuvant (3435) 3435
irradiation (3363) 3363
prospective studies (3192) 3192
gene expression (3126) 3126
radiotherapy, adjuvant (3124) 3124
neoplasm metastasis (3113) 3113
development and progression (3101) 3101
genetic aspects (3031) 3031
medical prognosis (3005) 3005
breast neoplasms (2970) 2970
pathology (2970) 2970
mice (2954) 2954
research article (2899) 2899
young adult (2882) 2882
quality-of-life (2877) 2877
studies (2818) 2818
proteins (2761) 2761
mortality (2754) 2754
biopsy (2626) 2626
obstetrics & gynecology (2626) 2626
metastases (2592) 2592
cancer research (2550) 2550
medical research (2547) 2547
article (2488) 2488
breast neoplasms - diagnostic imaging (2464) 2464
mammography (2451) 2451
neoplasms (2450) 2450
breast neoplasms - epidemiology (2374) 2374
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (210) 210
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (16) 16
Online Resources - Online (13) 13
Mt Sinai Hospital - Pathology (5) 5
Scarborough Hospital - General (4) 4
Credit Valley Hospital - Stacks (3) 3
New College (Ivey) - Stacks (3) 3
Scarborough Hospital - Online (3) 3
Gerstein Science - Circulation Desk (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Credit Valley Hospital - Reference (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - Birchmount (1) 1
St Josephs Health Centre - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (63183) 63183
German (1265) 1265
French (1170) 1170
Japanese (488) 488
Russian (431) 431
Italian (351) 351
Spanish (232) 232
Chinese (160) 160
Polish (122) 122
Dutch (105) 105
Portuguese (80) 80
Hungarian (78) 78
Czech (49) 49
Korean (38) 38
Danish (31) 31
Turkish (27) 27
Norwegian (25) 25
Swedish (22) 22
Bulgarian (17) 17
Romanian (16) 16
Hebrew (15) 15
Finnish (14) 14
Serbian (13) 13
Croatian (11) 11
Slovak (7) 7
Ukrainian (5) 5
Latvian (3) 3
Lithuanian (3) 3
Greek (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gene, ISSN 0378-1119, 12/2019, Volume 720, pp. 144088 - 144088
Secretory leukocyte protease inhibitor (SPLI) was a secreted protein which belongs to a member of whey acidic protein four-disulfide core family. In breast... 
Bioinformatics analysis | Secretory leukocyte proteinase inhibitor | Biomarker | Breast cancer | Index Medicus
Journal Article
Journal Article
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, ISSN 1756-9966, 03/2019, Volume 38, Issue 1, pp. 139 - 139
BackgroundNuciferine (NF), extracted from the leaves of N. nucifera Gaertn, has been shown to exhibit anti-tumor and anti-viral pharmacological properties. It... 
STAT3-Slug signaling pathway | NELUMBO-NUCIFERA | Nuciferine | Glioblastoma | PROLIFERATION | EMT | CANCER | SLUG | EPITHELIAL-MESENCHYMAL TRANSITION | SOX2 | REGULATOR | ONCOLOGY | RESISTANCE | CHECKPOINT | SOX2-AKT | Cell Survival - drug effects | Snail Family Transcription Factors - metabolism | Humans | Epithelial-Mesenchymal Transition - drug effects | Brain Neoplasms - drug therapy | Aporphines - administration & dosage | Brain Neoplasms - metabolism | Disease Progression | Aporphines - pharmacology | SOXB1 Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Antineoplastic Agents, Phytogenic - administration & dosage | Animals | Signal Transduction - drug effects | Mice, Nude | Cell Line, Tumor | Glioblastoma - metabolism | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Phytogenic - pharmacology | Glioblastoma - drug therapy | Proto-Oncogene Proteins c-akt - metabolism | STAT3 Transcription Factor - metabolism | Immunohistochemistry | Antiviral agents | Analysis | Brain tumors | Stem cells | Vincristine | Glioblastoma multiforme | Immunoglobulins | Brain cancer | Colorectal cancer | Breast cancer | Neuroblastoma | Gene expression | Drug resistance | Cancer therapies | Studies | Liver cancer | Chemotherapy | Medical prognosis | Cell cycle | Drug dosages | Apoptosis | SOX2-AKT/STAT3-Slug signaling pathway
Journal Article
BMC CANCER, ISSN 1471-2407, 04/2019, Volume 19, Issue 1, pp. 361 - 361
Background: Phase I trials aim to identify the recommended dose for further development. Health-related quality of life (HRQoL) could be a complement to the... 
Health-related quality of life | CLINICAL-TRIAL | SAFETY | Recommended phase II dose | CANCER | CHEMOTHERAPY | MOLECULARLY TARGETED AGENTS | Endpoint | PHARMACOKINETICS | ONCOLOGY | ALWAYS GO | Phase I trial | RADIOTHERAPY | DOSE SELECTION | Clinical trials | Care and treatment | Research | Analysis | Quality of life | Cancer
Journal Article
NPJ breast cancer, ISSN 2374-4677, 2019, Volume 5, Issue 1, pp. 7 - 9
Numerous studies have focused on the PI3K/AKT/mTOR pathway in estrogen receptor positive (ER) breast cancer (BC), as a linear signal transduction pathway and... 
Signal transduction | Breast cancer | Mutation | Kinases
Journal Article
Nature Reviews Disease Primers, ISSN 2056-676X, 12/2019, Volume 5, Issue 1, pp. 22 - 22
Journal Article
by Dai, ZJ and Tian, T and Wang, M and Yang, TL and Li, HT and Lin, S and Hao, Q and Xu, P and Deng, YJ and Zhou, LH and Li, N and Diao, Y
CANCER CELL INTERNATIONAL, ISSN 1475-2867, 01/2019, Volume 19, Issue 1, pp. 11 - 11
BackgroundEstrogen exposure is a widely known risk factor for BC. And the interaction of estrogen with estrogen receptor (ER) plays an important role in breast... 
PVUII | ONCOLOGY | Estrogen receptor genes | Susceptibility | STATISTICS | RISK | Breast cancer | XBAI | ESR2 GENE | RS1062577 | Polymorphism | Statistical analysis | Genes | Estrogens | Estrogen receptors | Risk analysis | Risk factors | Lymph nodes | Metastases | Confidence intervals | Studies | Hospitals | Womens health | Breast | Population | Health risk assessment | Deoxyribonucleic acid--DNA | Cancer
Journal Article
Journal Article